1) McMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure : prospective observational studies corrected for regression dilution bias. Lancet. 1990 ; 335 : 765-74.
2) SPRINT Research Group, Wright JT Jr, Williamson JD, et al. A randomized trial of Intensive versus standard blood?pressure control. N Engl J Med. 2015 ; 373 : 2103-16.
3) Whelton PK, Carey RM, Aronow WS, et al. ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults : a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018 ; 71 : e13-e115.
4) Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018 ; 39 : 3021-104.
5) 日本高血圧学会. 高血圧治療ガイドライン 2019. 東京 : ライフサイエンス出版 ; 2019.
6) 厚生労働省. 平成28年度国民健康・栄養調査データ.
7) Ohkubo T, Imai Y, Tsuji I, et al. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement : a population-based observation in Ohasama, Japan. J Hypertens. 1998 ; 16 : 971-5.
8) Niiranen TJ, Hanninen MR, Johansson J, et al. Home-measured blood pressure is a stronger predictor of cardiovascular risk than office blood pressure : The Finn-Home Study. Hypertension. 2010 ; 55 : 1346-51.
9) Kario K, Saito I, Kushiro T, et al. Morning home blood pressure is a strong predictor of coronary artery disease : The HONEST Study. J Am Coll Cardiol. 2016 ; 67 : 1519-27.
10) Sega R, Facchetti R, Bombelli M, et al. Prognostic value of ambulatory and home blood pressure compared with office blood pressure in the general population : follow-up results from the Pression Arteriose Monitorate e Loro Assocoazioni (PAMELA) study. Circulation. 2005 ; 111 : 1777-83.
11) Boggia J, Li Y, Thijs L, et al, International Database on Ambulatory blood pressure monitoring in relation to Cardiovascular Outcomes (IDACO) investigators. Prognostic accuracy of day versus night ambulatory blood pressure : a cohort study. Lancet. 2007 ; 370 : 1219-29.
12) Banegas JR, Ruilope LM, de la Sierra A, et al. Relationship between clinic and ambulatory blood-pressure measurements and mortality. N Engl J Med. 2018 ; 378 : 1509-20.
13) Kario K, Pickering TG, Matsuo T, et al. Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension. 2001 ; 38 : 852-7.
14) Kario K, Kanegae H, Tomitani N, et al. Nighttime blood pressure measured by home blood pressure monitoring as an independent predictor of cardiovascular events in general practice. Hypertension. 2019 ; 73 : 1240-8.
15) Muller JE, Tofler GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation. 1989 ; 79 : 733-43.
16) Kario K, Pickering TG, Umeda Y, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives : a prospective study. Circulation. 2003 ; 107 : 1401-6.
17) Li Y, Thijs L, Hansen TW, et al. International Database on Ambulatory blood pressure monitoring in relation to Cardiovascular Outcomes (IDACO) investigators. Prognostic value of the morning blood pressure surge in 5645 subjects from 8 populations. Hypertension. 2010 ; 55 : 1040-8.
18) Kario K. Essential Mannual of 24-hour Blood Pressure Management from Morning to Nocturnal Hypertension. London : Wiley-Blackwell ; 2015.
19) Kario K, Shimada K, Schwartz JE, et al. Silent and clinically overt stroke in older Japanese subjects with white-coat and sustained hypertension. J Am Coll Cardiol. 2001 ; 38 : 238-45.
20) Bobrie G, Chatellier G, Genes N, et al. Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA. 2004 ; 291 : 1342-9.
21) Fujiwara T, Yano Y, Hoshide S, et al. Association of cardiovascular outcomes with masked hypertension defined by home blood pressure monitoring in a Japanese general practice population. JAMA Cardiology. 2018 ; 3 : 583-90.
22) Narita K, Hoshide S, Kario K. Lowering the systolic blood pressure target in hypertensive patients : current controversies and future outlook. Expert Rev Cardiovasc Ther. 2018 ; 16 : 889-95.
24) Bundy JD, Li C, Stuchlik P, et al. Systolic blood pressure reduction and risk of cardiovascular disease and mortality. JAMA Cardiol. 2017 ; 2 : 775-81.
25) Kario K, Wang JG. Could 130/80 mmHg be adapted as the diagnostic threshold and management goal of hypertension in consideration of the characteristics of Asian populations? Hypertension. 2018 ; 71 : 979-84.
26) Shimada K, Kario K, Kushiro T, et al. Prognostic significance of on-treatment home and clinic blood pressure for predicting cardiovascular events in hypertensive patients in the HONEST study. J Hypertens. 2016 ; 34 : 1520-7.
27) Messerli FH, Bangalore S, Bavishi C, et al. Angiotensin-converting enzyme inhibitors in hypertension : to use or not to use? J Am Coll Cardiol. 2018 ; 71 : 1474-82.
28) Williams B, MacDonald TM, Morant S, et al. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2) : a randomized, double-blind, crossover trial. Lancet. 2015 ; 386 : 2059-68.